Company Overview of Ferring Holding SA
Ferring Holding SA, a biopharmaceutical company, identifies, develops, manufactures, and markets products in the fields of reproductive health, urology, gastroenterology, endocrinology, and osteoarthritis. It offers MINIRIN for bedwetting in children and nocturia in adults; FIRMAGON for advanced hormone-dependent prostate cancer; and TESTIM for treating men suffering from low testosterone. The company also provides MENOPUR and BRAVELLE ovarian-stimulating treatments used in the preparation for in-vitro fertilization; TRACTOCILE to treat pre-term labor; ZOMACTON, a recombinant human growth hormone used to treat growth failure in children; PENTASA for the treatment of inflammatory bowel diseas...
Chemin de la Vergognausaz 50
Founded in 1950
Key Executives for Ferring Holding SA
Executive Chairman and Chief Executive Officer
Chief Financial Officer and Executive Vice President
Senior Vice President of US Development and President of FIPCUS
President of Ferring Pharmaceuticals Inc and Chief Operating Officer of Ferring Pharmaceuticals Inc
Compensation as of Fiscal Year 2014.
Ferring Holding SA Key Developments
Ferring Presents at 2013 BIO Convention in China, Nov-11-2013
Nov 11 13
Ferring Presents at 2013 BIO Convention in China, Nov-11-2013 . Venue: China National Convention Center, No.7 Tianchen East Road, Chaoyang District, Beijing 100105, China.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
Sponsored Financial Commentaries